Samarkand Group PLC - Interim Results
Samarkand Group plc
("Samarkand", the "Company" or together with its subsidiaries the "Group")
Interim Results
Shift in Strategy to Owned Brands Progressing Well
Samarkand Group plc, (AQSE:SMK), the consumer brand owner and cross border eCommerce distribution services group announces its unaudited interim results for the half year ending
As stated in our annual results FY24, our future is as a scale up platform for meaningfully different, high potential, niche brands in the health and healing space, targeted at specific consumer segments with long term growth potential, specifically natural herbal health and beauty and fertility and reproductive health.
The Group has made strong progress in shifting its strategy to focus on growing our portfolio of owned brands (Napiers the Herbalists,
Financial Highlights
· Revenues decreased by 22% to
o Brand Ownership revenues up 14% to
o Brand Acceleration revenues of third party brands decreased by 57% to
o Distribution revenues remained flat at
· Gross margin decreased 22% to
· Adjusted EBITDA loss* reduced by 10% to
· Cash and cash equivalents were
*adjusted for restructuring costs, impairment on intangible assets, profit on disposal of Brand Asset and share based payments.
Operational Highlights
· Strong growth in owned brand revenues with H1 sales for our portfolio of owned brands Napiers the Herbalists,
· Napiers the Herbalists revenue grew over 100% in the
·
· Performance of recently acquired Optimised Energetics Ltd running ahead of expectations with owned brands Natures Greatest Secret and Benatural growing at over 100% and the flexible manufacturing capacity which is now part of the Group improving our speed to market and ability to respond to fast moving consumer trends
· Restructuring of
· Reduction in Group's adjusted EBITDA losses by 10% vs prior year and good progress made towards goal of monthly breakeven
Reaching monthly profitability remains our top priority and I'm pleased to report this strategy is bearing fruit with September bringing a profit of c.
For more information, please contact:
|
Samarkand Group plc |
|
|
|
|
|
|
|
|
Guild Financial Advisory Limited |
|
|
|
+44 (0) 7973839767 +44 (0) 7834458095 |
|
|
|
Notes to Editors
Samarkand is a consumer brand owner and distributor operating a scale up platform for niche, premium, multichannel, health and healing brands. Core owned brands include Napiers the Herbalists,
Founded in 2016, Samarkand is headquartered in Tonbridge,
For further information please visit https://www.samarkand.global/
CEO Review
Our focus in the first half of this financial year has been on implementing our strategic shift to a scale up platform for niche, differentiated health and healing brands. I am pleased to report strong performance of our owned brand portfolio in the period with Napiers the Herbalists revenues in the
Our owned brand portfolio in the
In parallel we have taken steps to restructure and simplify our
As a result of growth in our owned brands and reduction in
We have been successful in reducing adjusted EBITDA losses vs prior year by 11%. We have taken restructuring and cost actions in the period as we reconfigure our resources around our owned brands, which we expect to materialise in terms of improved margins in H2.
Losses in H1, on an adjusted basis, have been slightly higher than our initial expectation as a result of restructuring costs and a faster than forecast decline in revenues from the
We remain of the view that the value of the Company, in terms of its assets, capabilities and potential, is not currently reflected in the share price, and are focused on improving the underlying performance of the business, reaching profitability and increasing shareholder value.
Outlook
Our immediate focus is to continue to grow our portfolio of owned brands profitably, leveraging our platform resources effectively across all our brands. We are confident in the growth momentum and future potential of our owned brands and will continue to work towards our goal of reaching consistent monthly profitability.
Our overall goal is to establish Samarkand as a scale up platform for niche differentiated premium brands, with a shared playbook for growth acceleration and efficient operations. In the future we may explore opportunities to invest at a higher rate behind our current owned brand portfolio and may consider bolt on acquisitions in our health and healing sweet spot.
Chief Executive Officer
FINANCIAL REVIEW
Overview
During the period the Group's revenues decreased by 22% to
Brand ownership revenue is up 14% to
Adjusted EBITDA loss improved by 10% from
Operating expenses
Selling and distribution expenses decreased to 31% (H1 2024: 34%) of revenue, as a result of a change in sales mix and successful cost minimising actions in the last six months.
Administrative expenses, excluding one-off costs such as a share-based payment expense and restructuring related costs, increased to 39% (H1 2024: 34%) of revenue as a faster than forecast decline in sales of our third-party brands in
Earnings per share
Basic earnings per share was 0.13p (H1 2024: loss 5.19p per share) and diluted earnings per share was 0.12p (H1 2024: loss 5.19p per share).
Net debt
|
|
Sep-24 |
Sep-23 |
Mar-24 |
|
Cash and cash equivalents |
681,688 |
1,658,643 |
867,524 |
|
Right-of-use lease liabilities |
(885,579) |
(418,101) |
(716,400) |
|
Borrowings |
(1,798,291) |
(1,459,278) |
(1,496,488) |
|
Net debt |
(2,002,182) |
(218,736) |
(1,345,364) |
At the period end, the Group's net debt position was
Inventories
The Group reduced gross inventories from
Depreciation and amortisation
The total depreciation and amortisation costs were
Adjusted EBITDA loss
Adjusted EBITDA loss improved by 10% from
Condensed Consolidated Statement of Comprehensive Income
For the six-month period ended
|
|
|
Period ended |
|
Period ended |
|
Year ended |
|
|||||
|
|
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
|
|||||
|
|
Notes |
£ |
|
£ |
|
£ |
|
|||||
|
Revenue |
3 |
6,323,275 |
|
8,132,309 |
|
16,922,669 |
|
|||||
|
Cost of sales |
3 |
(2,522,939) |
|
(3,208,355) |
|
(6,695,544) |
|
|||||
|
Gross profit |
|
3,800,336 |
|
4,923,954 |
|
10,227,125 |
|
|||||
|
Selling and distribution expenses |
|
(1,953,349) |
|
(2,805,574) |
|
(5,715,219) |
|
|||||
|
Administrative expenses |
4 |
(1,529,367) |
|
(4,450,721) |
|
(8,135,412) |
|
|||||
|
Adjusted EBITDA |
|
(597,700) |
|
(664,195) |
|
(893,366) |
|
|||||
|
Restructuring costs |
5 |
(93,127) |
|
(77,292) |
|
(457,594) |
|
|||||
|
Impairment on intangible assets |
5 |
- |
|
(1,489,580) |
|
(2,080,746) |
|
|||||
|
Profit on disposal of Brand Asset |
|
1,083,127 |
|
- |
|
- |
|
|||||
|
Share-based payment and related expenses |
5 |
(75,680) |
|
(101,274) |
|
(191,800) |
|
|||||
|
EBITDA |
|
317,620 |
|
(2,332,341) |
|
(3,623,506) |
|
|||||
|
Depreciation and amortisation |
|
(185,941) |
|
(627,085) |
|
(989,208) |
|
|||||
|
Operating profit/ (loss) |
|
131,679 |
|
(2,959,426) |
|
(4,612,714) |
|
|||||
|
Finance income |
|
3,801 |
|
2,051 |
|
6,856 |
|
|||||
|
Finance costs |
|
(108,587) |
|
(106,084) |
|
(261,722) |
|
|||||
|
Profit/(loss) before taxation |
|
26,893 |
|
(3,063,459) |
|
(4,867,580) |
|
|||||
|
Taxation |
|
21,452 |
|
13,627 |
|
69,520 |
|
|||||
|
Profit/(loss) after taxation |
|
48,345 |
|
(3,049,832) |
|
(4,798,060) |
|
|||||
|
Other comprehensive income: |
|
|
|
|
|
|
|
|||||
|
Exchange differences on translation of foreign operations |
|
|
|
|
|
|
|
|||||
|
|
(1,349) |
|
(6,034) |
|
(7,227) |
|
||||||
|
Items that may be reclassified to profit and loss in subsequent periods |
|
|
|
|
|
|
|
|||||
|
|
(1,349) |
|
(6,034) |
|
(7,227) |
|
||||||
|
Total comprehensive profit/(loss) for the period |
|
46,996 |
|
(3,055,866) |
|
(4,805,287) |
|
|||||
|
|
|
|
|
|
|
|
|
|||||
|
Profit/(loss) attributable to: |
|
|
|
|
|
|
|
|||||
|
Equity holders of the Company |
|
73,430 |
|
(3,029,365) |
|
(4,756,999) |
|
|||||
|
Non-controlling interests |
|
(25,085) |
|
(20,467) |
|
(41,061) |
|
|||||
|
|
|
48,345 |
|
(3,049,832) |
|
(4,798,060) |
|
|||||
|
|
|
|
|
|
|
|
|
|||||
|
Comprehensive profit/(loss) attributable to: |
|
|
|
|
|
|
|
|||||
|
Equity holders of the Company |
|
72,081 |
|
(3,035,399) |
|
(4,764,226) |
|
|||||
|
Non-controlling interests |
|
(25,085) |
|
(20,467) |
|
(41,061) |
|
|||||
|
|
|
46,996 |
|
(3,055,866) |
|
(4,805,287) |
|
|||||
|
Earnings/(loss) per share (basic and diluted) |
|
|
|
|
|
|
||||||
|
Basic |
6 |
0.0013 |
|
(0.0519) |
|
(0.0815) |
||||||
|
Diluted |
6 |
0.0012 |
|
(0.0519) |
|
(0.0815) |
||||||
Condensed Consolidated Statement of Financial Position
For the six-month ended
|
|
|
|
|
|
|
Restated |
|
|
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
|
|
Notes |
£ |
|
£ |
|
£ |
|
ASSETS |
|
|
|
|
|
|
|
Intangible assets |
7 |
5,600,129 |
|
5,551,141 |
|
4,585,661 |
|
Property, plant and equipment |
|
247,948 |
|
160,291 |
|
77,092 |
|
Right-of-use assets |
|
798,083 |
|
352,661 |
|
688,628 |
|
Deferred Tax Asset |
|
217,721 |
|
- |
|
179,350 |
|
Non-current assets |
|
6,863,881 |
|
6,064,093 |
|
5,530,731 |
|
Inventories |
8 |
1,881,136 |
|
2,572,847 |
|
2,370,941 |
|
Trade receivables |
|
1,312,673 |
|
1,343,409 |
|
1,175,380 |
|
Corporation tax recoverable |
|
59,377 |
|
126,616 |
|
59,376 |
|
Other receivables and prepayments |
|
907,466 |
|
540,997 |
|
625,248 |
|
Cash and cash equivalents |
|
681,688 |
|
1,658,643 |
|
867,524 |
|
Held for sale |
|
- |
|
- |
|
216,597 |
|
Current assets |
|
4,842,340 |
|
6,242,512 |
|
5,315,066 |
|
Total assets |
|
11,706,221 |
|
12,306,605 |
|
10,845,797 |
|
|
|
|
|
|
|
|
|
EQUITY AND LIABILITIES |
|
|
|
|
|
|
|
Share capital |
9 |
583,582 |
|
583,582 |
|
583,582 |
|
Share premium |
|
22,954,413 |
|
22,954,413 |
|
22,954,413 |
|
Merger relief reserve |
|
(2,063,814) |
|
(2,063,814) |
|
(2,063,814) |
|
Accumulated loss |
|
(16,801,093) |
|
(15,829,992) |
|
(16,950,203) |
|
Currency translation reserve |
|
(87,936) |
|
(85,394) |
|
(86,587) |
|
Total equity attributable to parent |
|
4,585,152 |
|
5,558,795 |
|
4,437,391 |
|
Non-controlling interest |
|
(205,388) |
|
(159,709) |
|
(180,303) |
|
Total equity |
|
4,379,764 |
|
5,399,086 |
|
4,257,088 |
|
|
|
|
|
|
|
|
|
Right-of-use lease liabilities |
|
719,478 |
|
107,066 |
|
617,819 |
|
Borrowings |
|
87,176 |
|
1,403,516 |
|
1,434,895 |
|
Deferred tax liability |
|
548,653 |
|
334,257 |
|
492,787 |
|
Accrued liabilities |
|
430,000 |
|
512,441 |
|
- |
|
Total non-current liabilities |
|
1,785,307 |
|
2,357,280 |
|
2,545,501 |
|
|
|
|
|
|
|
|
|
Trade and other payables |
|
3,379,027 |
|
3,521,220 |
|
3,401,814 |
|
Deferred revenue |
|
284,906 |
|
662,222 |
|
480,220 |
|
Borrowings |
|
1,711,116 |
|
55,762 |
|
61,593 |
|
Right-of-use lease liabilities |
|
166,101 |
|
311,035 |
|
99,581 |
|
Total current liabilities |
|
5,541,150 |
|
4,550,239 |
|
4,043,208 |
|
Total liabilities |
|
7,326,457 |
|
6,907,519 |
|
6,588,709 |
|
|
|
|
|
|
|
|
|
Total liabilities and equity |
|
11,706,221 |
|
12,306,605 |
|
10,845,797 |
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Changes in Equity
For the six-month period ended
|
|
|
Share Capital |
Share Premium |
Merger relief reserve |
Currency Translation reserve |
Accumulated Loss (Restated) |
Non-controlling interests |
Total equity |
|
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
583,582 |
22,954,413 |
(2,063,814) |
(86,587) |
(16,950,203) |
(180,303) |
4,257,088 |
|
|
Profit/(loss) after taxation |
- |
- |
- |
- |
73,430 |
(25,085) |
48,345 |
|
|
Other comprehensive loss |
- |
- |
- |
(1,349) |
- |
- |
(1,349) |
|
|
Total comprehensive profit/(loss) for the period |
- |
- |
- |
(1,349) |
73,430 |
(25,085) |
46,996 |
|
|
Share based payments |
- |
- |
- |
- |
75,680 |
- |
75,680 |
|
|
|
- |
- |
- |
- |
75,680 |
- |
75,680 |
|
|
Balance at |
583,582 |
22,954,413 |
(2,063,814) |
(87,936) |
(16,801,093) |
(205,388) |
4,379,764 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
583,582 |
22,954,413 |
(2,063,814) |
(79,360) |
(12,901,901) |
(139,242) |
8,353,678 |
|
|
Loss after taxation |
- |
- |
- |
- |
(3,029,365) |
(20,467) |
(3,049,832) |
|
|
Other comprehensive loss |
- |
- |
- |
(6,034) |
- |
- |
(6,034) |
|
|
Total comprehensive loss for the period |
- |
- |
- |
(6,034) |
(3,029,365) |
(20,467) |
(3,055,866) |
|
|
Share based payments |
- |
- |
- |
- |
101,274 |
- |
101,274 |
|
|
|
- |
- |
- |
- |
101,274 |
- |
101,274 |
|
|
Balance at |
583,582 |
22,954,413 |
(2,063,814) |
(85,394) |
(15,829,992) |
(159,709) |
5,399,086 |
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Cash Flows
For the six-month period ended
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
|
|
£ |
|
£ |
|
£ |
|
Cash flows from operating activities |
|
|
|
|
|
|
Profit/(loss) after taxation |
48,345 |
|
(3,049,832) |
|
(4,798,060) |
|
Cash flow from operations reconciliation: |
|
|
|
|
|
|
Depreciation and amortisation |
185,941 |
|
627,086 |
|
989,208 |
|
Impairment on intangible assets |
- |
|
1,489,580 |
|
2,080,746 |
|
Profit on disposal of Brand Asset |
(1,113,152) |
|
|
|
|
|
Finance costs |
92,149 |
|
48,445 |
|
113,225 |
|
Finance income |
(3,801) |
|
(2,051) |
|
(6,856) |
|
Share option expense |
75,680 |
|
101,274 |
|
191,800 |
|
Income tax credit |
(21,452) |
|
(13,627) |
|
(69,520) |
|
Working capital adjustments: |
|
|
|
|
|
|
Inventories |
71,623 |
|
(360,620) |
|
(158,714) |
|
Trade and other receivables |
228,535 |
|
521,999 |
|
628,522 |
|
Trade and other payables |
(459,735) |
|
629,941 |
|
187,942 |
|
Cash generated (used in) operating activities |
(895,867) |
|
(7,805) |
|
(841,707) |
|
Corporation tax (paid)/received |
(49,706) |
|
- |
|
224,615 |
|
Net cash generated (used in) operating activities |
(945,573) |
|
(7,805) |
|
(8,047,840) |
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
Purchase of property, plant and equipment |
(100,369) |
|
(1,654) |
|
(37,484) |
|
Disposal of property, plant and equipment |
1,076 |
|
1,565 |
|
84,206 |
|
Disposal of right of use asset |
- |
|
- |
|
(47,813) |
|
Disposal of intangible asset |
5,629 |
|
- |
|
16,435 |
|
Payment of intangible assets |
(5,724) |
|
(147,929) |
|
(220,734) |
|
Disposal of Brand Asset |
1,279,337 |
|
- |
|
- |
|
Acquistion of Subsidiary, net of cash acquired |
(576,692) |
|
- |
|
- |
|
Interest received |
3,801 |
|
2,051 |
|
6,856 |
|
Net cash (used in) investing activities |
607,058 |
|
(145,967) |
|
(198,534) |
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
Repayment of right-of-use lease liabilities |
(55,601) |
|
(164,888) |
|
(283,218) |
|
Proceeds from other loans |
297,181 |
|
- |
|
31,363 |
|
Interest paid |
(14,253) |
|
(9,883) |
|
(21,717) |
|
Repayment of borrowings |
(72,796) |
|
(30,324) |
|
(54,857) |
|
Net cash (used in)/from financing activities |
154,531 |
|
(205,095) |
|
(328,429) |
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
(183,984) |
|
(358,867) |
|
(1,144,055) |
|
Cash and cash equivalents at beginning of period |
867,524 |
|
2,017,150 |
|
2,017,150 |
|
Effect of FX changes on cash and cash equivalents |
(1,852) |
|
360 |
|
(5,571) |
|
Cash and cash equivalents at end of period |
681,688 |
|
1,658,643 |
|
867,524 |
|
|
|
|
|
|
|
Notes to the Consolidated Financial Statements
For the period ended
1. General information
Samarkand Group plc was incorporated in
2. Basis of preparation and measurement
(a) Basis of preparation
The condensed consolidated interim financial statements of Samarkand Group plc and its subsidiaries (together referred to as the "Group"), comprises the results of the Group for the 6 months ended
The financial information in this interim report has been prepared in accordance with
The financial information for the year ended
Unless otherwise stated, the financial statements are presented in Pounds Sterling (£) which is the currency of the primary economic environment in which the Group operates.
Transactions in foreign currencies are translated into £ at the rate of exchange on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date. The resulting gain or loss is reflected in the "Consolidated Statements of Comprehensive Income" within either "Finance income" or "Finance costs".
The financial statements have been prepared under the historical cost convention except for certain financial instruments that have been measured at fair value.
The financial statements have been prepared on the going concern basis, which contemplates the continuity of normal business activity and the realisation of assets and the settlement of liabilities in the normal course of business. The directors of Samarkand Group plc have reviewed the Group's overall position and outlook and are of the opinion that the Group is sufficiently well funded to be able to operate as a going concern for at least the next twelve months from the date of approval of these financial statements.
Going Concern
For the year ended
The Group's owned brands have performed ahead of expectations in the period, with strong revenue growth and profitable contribution from Napiers,
The Directors recognise the importance of moving the Group into profitability and have made significant progress towards this goal, with the month of September generating adjusted EBITDA profit of c£40k.
In addition, the Directors are actively exploring additional funding options including trade financing and other strategic opportunities to support the Group's operations and long-term viability. In
Despite the cost base reduction and ongoing exploration of additional funding, in the event that trading does not proceed as planned and in conjunction with the loan with Global Smollan Holdings becoming due in
Although there are material uncertainties, several mitigating factors have been considered by the Directors in their assessment of the going concern assumption. These include the steps taken to further reduce costs and the progress made in exploring various strategic options to raise additional funds. The Directors believe that these factors, will enable the Group to overcome the identified challenges and continue its operations.
To address the material uncertainties, the Directors will continue to closely monitor the Group's financial performance, cash flow projections, and market conditions. They will continue to proactively manage the Group's cost base, seeking further efficiencies where possible.
The Directors are confident in the Group's ability to mitigate the identified risks and uncertainties. As a result, the financial statements have been prepared on a going concern basis, acknowledging the material uncertainties that may cast significant doubt on the Group's ability to continue as a going concern.
(b) Basis of consolidation
The Consolidated Group financial statements comprises the financial statements of Samarkand Group plc and its subsidiaries.
A subsidiary is defined as an entity over which Samarkand Group plc has control. Samarkand Group plc controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Changes in the Group's interest in a subsidiary that do not result in a loss of control are accounted for as equity transactions. The carrying amounts of the Group's interests and the non-controlling interests are adjusted to reflect the changes in their relative interests in the subsidiary. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recognised directly in equity and attributed to owners of the Company.
Intra-group transactions, balances and unrealised gains on transactions are eliminated; unrealised losses are also eliminated unless cost cannot be recovered. Where necessary, adjustments are made to the financial statements of subsidiaries to ensure consistency of accounting policies with those of the Group.
The total comprehensive income of non-wholly owned subsidiaries is attributed to owners of the parent and to the non-controlling interests in proportion to their relative ownership interests.
(c) Restatement of Prior Year Opening Balances
During the period the Group reviewed the classification and presentation of the accruals made in relation to the Bonus Scheme for the financial year ending
|
|
As reported |
|
Impact of Restatement |
|
Restated |
|
Consolidated statement of financial position |
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
Trade and other payables |
(3,897,739) |
|
495,925 |
|
(3,401,814) |
|
Accumulated loss |
(17,446,128) |
|
495,925 |
|
(16,950,203) |
3. Segmental analysis
An analysis of the Group's revenue and cost of sales is as follows:
|
|
Unaudited |
|
Unaudited |
|
Audited |
|
|
|
|
|
|
|
|
Revenue analysed by class of business: |
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
Brand ownership |
4,130,094 |
|
3,615,063 |
|
7,748,048 |
|
Brand acceleration |
1,770,107 |
|
4,081,351 |
|
8,204,409 |
|
Distribution |
360,463 |
|
355,635 |
|
740,999 |
|
Nomad Checkout |
48,203 |
|
69,157 |
|
149,337 |
|
Other |
14,408 |
|
11,103 |
|
79,876 |
|
Total revenue |
6,323,275 |
|
8,132,309 |
|
16,922,669 |
|
|
|
|
|
|
|
|
Cost of sale by business unit: |
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
Brand ownership |
1,272,027 |
|
1,323,972 |
|
2,772,796 |
|
Brand acceleration |
1,101,391 |
|
1,680,524 |
|
3,539,317 |
|
Distribution |
149,520 |
|
183,627 |
|
351,413 |
|
Nomad Checkout |
- |
|
20,231 |
|
31,707 |
|
Other |
- |
|
- |
|
311 |
|
Total cost of sale |
2,522,939 |
|
3,208,355 |
|
6,695,544 |
Segment assets:
The non-current assets of the Group are not measured or reported internally on a segmental basis as they are not considered to be attributable to any specific business segment.
|
|
Unaudited |
|
Unaudited |
|
Audited |
|
|
|
|
|
|
|
|
Revenue by geographical destination: |
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
3,625,447 |
|
3,076,487 |
|
6,529,226 |
|
|
2,473,549 |
|
4,829,173 |
|
9,764,724 |
|
Rest of the World |
224,279 |
|
226,649 |
|
628,719 |
|
|
|
|
|
|
|
|
Total revenue |
6,323,275 |
|
8,132,309 |
|
16,922,669 |
4. Expenses by nature
An analysis of the Group's expenses by nature is as follows:
|
|
|
Unaudited |
|
Unaudited |
|
Audited |
|
|
|
30 September 2024 |
|
30 September 2023 |
|
31 March 2024 |
|
Administrative expenses: |
|
£ |
|
£ |
|
£ |
|
Property costs |
|
102,142 |
|
125,386 |
|
246,956 |
|
Staff costs |
|
1,747,184 |
|
2,039,593 |
|
3,932,703 |
|
Professional fees |
|
275,405 |
|
221,678 |
|
476,932 |
|
Other |
|
318,956 |
|
395,918 |
|
748,681 |
|
Impairment on intangible assets |
|
- |
|
1,489,580 |
|
2,080,746 |
|
Restructuring costs |
|
93,127 |
|
77,292 |
|
457,594 |
|
Share based payment charge |
|
75,680 |
|
101,274 |
|
191,800 |
|
Profit on disposal of Brand Asset |
|
(1,083,127) |
|
- |
|
- |
|
Total administrative expenses |
|
1,529,367 |
|
4,450,721 |
|
8,135,412 |
5. Adjusted EBITDA
EBITDA and Adjusted EBITDA are non-GAAP measures and exclude exceptional items, depreciation, and amortisation. Exceptional items are those items the Group considers to be non-recurring or material in nature that may distort an understanding of financial performance or impair comparability.
Adjusted EBITDA is stated before exceptional items as follows:
|
|
Unaudited |
|
Unaudited |
|
Audited |
|
|
30 September 2024 |
|
30 September 2023 |
|
31 March 2024 |
|
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
Restructuring costs |
(93,127) |
|
(77,292) |
|
(457,594) |
|
Share based payment charge |
(75,680) |
|
(101,274) |
|
(191,800) |
|
Profit on disposal of Brand Asset |
1,083,127 |
|
|
|
|
|
Impairment on intangible assets |
- |
|
(1,486,580) |
|
(2,080,746) |
|
|
914,320 |
|
(1,665,146) |
|
(2,730,140) |
|
|
|
|
|
|
|
6. Earnings per share
|
|
Unaudited |
Unaudited |
Audited |
|
|
30 September 2024 |
30 September 2023 |
31 March 2024 |
|
|
£ |
£ |
£ |
|
|
|
|
|
|
Basic earnings/(loss) per share |
0.13 pence |
(5.19) pence |
(8.15) pence |
|
Diluted earnings/(loss) per share |
0.12 pence |
(5.19) pence |
(8.15) pence |
|
|
|
|
|
|
Earnings |
|
|
|
|
Profit/(loss) for the purpose of basic and diluted earnings per share |
73,430 |
(3,029,365) |
(4,756,999) |
|
|
|
|
|
|
Number of shares |
|
|
|
|
Basic and diluted weighted average number of shares in issue |
58,358,201 |
58,358,201 |
58,358,201 |
7. Intangible assets
|
|
Development costs |
Trademarks |
Brands |
Goodwill |
Website |
Total |
|
|
£ |
£ |
£ |
£ |
£ |
£ |
|
Cost |
|
|
|
|
|
|
|
At 1 April 2024 |
3,587,428 |
64,988 |
2,024,175 |
2,813,283 |
69,350 |
8,559,224 |
|
Additions |
- |
1,503 |
- |
- |
- |
1,503 |
|
Disposal |
- |
(6,454) |
- |
- |
- |
(6,454) |
|
Acquisitions |
- |
- |
249,832 |
840,221 |
- |
1,090,053 |
|
At 30 September 2024 |
3,587,428 |
60,037 |
2,274,007 |
3,653,504 |
69,350 |
9,644,326 |
|
Amortisation |
|
|
|
|
|
|
|
At 1 April 2024 |
3,587,428 |
28,225 |
308,130 |
10,236 |
39,544 |
3,973,563 |
|
Amortisation charge |
- |
3,379 |
66,312 |
- |
5,486 |
75,176 |
|
Disposal |
- |
(4,543) |
- |
- |
- |
(4,543) |
|
At 30 September 2024 |
3,587,428 |
27,061 |
374,442 |
10,236 |
45,030 |
4,044,197 |
|
|
|
|
|
|
|
|
|
Net book value |
|
|
|
|
|
|
|
At 31 March 2024 |
- |
36,763 |
1,716,045 |
2,803,047 |
29,806 |
4,585,661 |
|
At 30 September 2024 |
- |
32,975 |
1,899,565 |
3,643,268 |
24,320 |
5,600,129 |
|
|
Development costs |
Trademarks |
Brands |
Goodwill |
Website |
Total |
|
|
£ |
£ |
£ |
£ |
£ |
£ |
|
Cost |
|
|
|
|
|
|
|
At 1 April 2023 |
3,406,596 |
118,220 |
2,484,091 |
2,829,718 |
70,980 |
8,909,605 |
|
Additions |
142,897 |
5,032 |
- |
- |
- |
147,929 |
|
At 30 September 2023 |
3,549,493 |
123,252 |
2,484,091 |
2,829,718 |
70,980 |
9,057,534 |
|
|
|
|
|
|
|
|
|
Amortisation |
|
|
|
|
|
|
|
At 1 April 2023 |
1,066,292 |
46,611 |
433,640 |
- |
24,178 |
1,570,721 |
|
Amortisation charge |
347,406 |
8,153 |
80,980 |
- |
9,553 |
446,092 |
|
Impairment* |
1,489,580 |
- |
- |
- |
- |
1,489,580 |
|
At 30 September 2023 |
2,903,278 |
54,764 |
514,620 |
- |
33,731 |
3,506,393 |
|
|
|
|
|
|
|
|
|
Net book value |
|
|
|
|
|
|
|
At 31 March 2023 |
2,340,304 |
71,609 |
2,050,451 |
2,829,718 |
46,802 |
7,338,884 |
|
At 30 September 2023 |
646,215 |
68,488 |
1,969,471 |
2,829,718 |
37,249 |
5,551,141 |
8. Inventories
|
|
|
|
|
|
|
|
|
|
|
30 September 2024 |
|
30 September 2023 |
|
31 March 2024 |
|
|
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
Finished goods |
|
2,148,220 |
|
3,112,475 |
|
2,770,112 |
|
Provision for obsolescence |
|
(267,084) |
|
(539,628) |
|
(399,171) |
|
Total inventories |
|
1,881,136 |
|
2,572,847 |
|
2,370,941 |
|
|
|
|
|
|
|
|
|
Cost of inventory recognised in profit and loss |
|
2,522,939 |
|
3,208,355 |
|
6,695,544 |
|
|
|
|
|
|
|
|
9. Share capital
|
|
|
Number of shares |
|
Share capital |
|
|
|
No. |
|
£ |
|
At 30 September 2023, 31 March 2024 and 30 September 2024 |
|
58,358,201 |
|
583,581 |
10. Notes to the statements of cash flows
Net debt reconciliation:
|
|
Opening balances |
Cash flows |
Non-cash movements |
Closing balances |
|
|
£ |
£ |
£ |
£ |
|
Six-month period ended 30 September 2024 |
|
|
|
|
|
Cash and cash equivalents |
867,524 |
(183,983) |
(1,853) |
681,688 |
|
Right of use lease liabilities |
(716,400) |
55,601 |
(224,780) |
(885,579) |
|
Borrowings |
(1,496,488) |
(224,385) |
(77,418) |
(1,798,291) |
|
Totals |
(1,345,364) |
(352,767) |
(304,051) |
(2,002,182) |
|
|
|
|
|
|
|
Six-month period ended 30 September 2023 |
|
|
|
|
|
Cash and cash equivalents |
2,017,150 |
(358,867) |
360 |
1,658,643 |
|
Right of use lease liabilities |
(573,785) |
164,888 |
(9,204) |
(418,101) |
|
Borrowings |
(1,453,298) |
30,324 |
(36,304) |
(1,459,278) |
|
Totals |
(9,933) |
(163,655) |
(45,148) |
(218,736) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE